Author(s):
Rahul U. Rathod, Pawankumar R. Bawadankar, Bhaskar R. Pavar, Ajay G. Bijawe, Sachin M. Nilwarn
Email(s):
rahulrathodr780@gmail.com
DOI:
10.52711/2231-5659.2025.00057 
Address:
Rahul U. Rathod, Pawankumar R. Bawadankar, Bhaskar R. Pavar, Ajay G. Bijawe, Sachin M. Nilwarn*
Alfa Biomed India Private Limited, Road Ahirwade, Maval, Pune–412106.
*Corresponding Author
Published In:
Volume - 15,
Issue - 4,
Year - 2025
ABSTRACT:
Computer System Validation (CSV) is a fundamental requirement in the pharmaceutical industry to ensure the reliability, data integrity, and security of computerized systems operating in GxP regulated environments. This review underscores the critical role of CSV in safeguarding patient safety and achieving compliance with international regulatory standards, including FDA 21 CFR Part 11 and ISPE GAMP 5 guidelines. Structured validation methodologies particularly risk-based approaches such as the V-Model and Agile are explored for their effectiveness in maintaining the validated state of systems throughout their lifecycle. The article examines common CSV challenges, including poorly defined user requirements, weak change control, insufficient testing, and inadequate traceability, and discusses their implications on regulatory compliance. Through the analysis of actual FDA inspection findings, the review highlights frequent deficiencies such as incomplete validation documentation, data integrity breaches, and audit trail failures. These issues are mapped to underlying CSV gaps, emphasizing the importance of proactive planning, comprehensive documentation, and routine review practices. The review concludes with practical preventive measures that pharmaceutical companies can adopt to reduce regulatory risk, enhance system robustness, and foster a culture of compliance and quality in computerized system environments.
Cite this article:
Rahul U. Rathod, Pawankumar R. Bawadankar, Bhaskar R. Pavar, Ajay G. Bijawe, Sachin M. Nilwarn. Review on Computer System Validation in Regulated Pharma Environments: Classification, Lifecycle Models, Compliance Challenges, and FDA Expectations. Asian Journal of Research in Pharmaceutical Sciences. 2025; 15(4):388-4. doi: 10.52711/2231-5659.2025.00057
Cite(Electronic):
Rahul U. Rathod, Pawankumar R. Bawadankar, Bhaskar R. Pavar, Ajay G. Bijawe, Sachin M. Nilwarn. Review on Computer System Validation in Regulated Pharma Environments: Classification, Lifecycle Models, Compliance Challenges, and FDA Expectations. Asian Journal of Research in Pharmaceutical Sciences. 2025; 15(4):388-4. doi: 10.52711/2231-5659.2025.00057 Available on: https://ajpsonline.com/AbstractView.aspx?PID=2025-15-4-7
REFERENCES:
1. Singh A, Sharma P, Gupta R. Computerized system validation in pharma. J Drug Deliv Ther. 2018; 8(S6): 359–65. doi:10.22270/jddt. v8i6-s.2102
2. Katre M, Deshpande R, Patil S. Review on regulatory aspects of CSV in pharma. Int J Pharm Sci. 2024; 2(7): 1012–9. doi:10.5281/zenodo.12739502
3. Raja JR, Sinha V, Mehta T. Quality assurance through computer validation: A review. J Pharm Qual Assur. 2024. doi:10.7759/cureus.67555
4. Rusjan B. Quality systems and compliance risks in GxP environments. J Contemp Manag Issues. 2020; 25(2): 1–23. Available from: https://hrcak.srce.hr/247329
5. The Manufacturing Chemist. The right validation model: practical considerations and applications. Manuf Chemist. 2021.
6. Walia G, Neri D. Computer software assurance and critical thinking. Pharm Eng. 2024 Mar/Apr. Available from: https://ispe.org/pharmaceutical-engineering/march-april-2024/computer-software-assurance-and-critical-thinking
7. Food and Drug Law Institute advancing the transition to computer software assurance. FDLI J. 2023. Available from: https://www.fdli.org/2023/05/advancing-the-transition-to-computer-software-assurance
8. Uzzaman S. Computer systems validation: a systems engineering approach. Pharm Eng. 2003; 23(3): 1–10.
9. Yogesh P, Kumari D, Thakur R. Validation of computerized systems in pharmaceuticals. World J Pharm Res. 2015; 4(9): 444–54.
10. Bhaskar R, Bawadankar P, Bijawe A, Nilwarn S. Review on computer system validation in pharma industry. Int J Pharm Res Appl. 2023; 8: 1759–64.
11. Savitha S, Kathiresan K. Review on regulatory guidelines for CSV. Int J Biol Pharm Allied Sci. 2022; 11(11): 5257–67. doi:10.31032/IJBPAS/2022/11.11.6567
12. Dhatchanamoorthi N, Kamaraj R. Validation of computerized systems: A regulatory approach. Res J Pharm Technol. 2020; 13(11): 5591–4. doi:10.5958/0974-360X.2020.00975.0
13. Hesham AM, Patan IK. A review on software validation requirements in pharma. Open Access J Pharm Res. 2020; 4(4): 000219. doi:10.23880/oajpr-16000219
14. Weichel P. 4 FDA observations that can be avoided with good CSV practices. J Valid Technol. Available from: https://blog.montrium.com/experts/4-fda-observations-that-can-be-avoided-with-good-csv-practices
15. Bjarnason E, Wnuk K, Regnell B. Aligning requirements with VandV: A literature review. Software Eng Rev. 2023.
16. ISPE. GAMP 5: A Risk-Based Approach to Compliant GxP Computerized Systems. Tampa, FL: International Society for Pharmaceutical Engineering; 2008.
17. ISPE. GAMP 5 Guide: A Risk-Based Approach to Compliant GxP Computerized Systems. 2nd ed. Tampa, FL: ISPE; 2022.
18. U.S. Food and Drug Administration. 21 CFR Part 11 – Electronic Records; Electronic Signatures. Washington, DC: FDA; 1997.
19. International Council for Harmonisation (ICH). ICH Q9: Quality Risk Management. Geneva: ICH; 2005.
20. International Council for Harmonisation (ICH). ICH Q10: Pharmaceutical Quality System. Geneva: ICH; 2008.
21. European Commission. EudraLex - Volume 4 - GMP Guidelines – Annex 11: Computerised Systems. Brussels: European Medicines Agency; 2011.
22. U.S. Food and Drug Administration. General Principles of Software Validation; Final Guidance for Industry and FDA Staff. Rockville, MD: FDA; 2002.
23. U.S. Food and Drug Administration. 21 CFR Part 11: Electronic Records; Electronic Signatures. Available from: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart=11
24. ISPE GAMP® Community of Practice. GAMP® 5 FAQs and Updates. 2022. Available from: https://ispe.org
25. Montrium. 4 FDA observations that can be avoided with good CSV practices. Available from: https://blog.montrium.com/experts/4-fda-observations-that-can-be-avoided-with-good-csv-practices
26. Part11Solutions. FDA warning letters for CSV failures. Available from: https://part11solutions.com/fda-warning-letters/